Home › DHA Speciality › Specialist Neurology (NRO5011)

Master Specialist Neurology (NRO5011)
for DHA Speciality

Access 268+ high-yield questions tailored for the 2026 syllabus. Includes AI-powered explanations and performance tracking.

Start Free Practice View Full Syllabus
HIGH YIELD NOTES Updated June 2026 · ~5 min read

Core Concepts

Specialist Neurology covers disorders of the central (brain, spinal cord) and peripheral nervous systems (nerves, neuromuscular junction, muscles). Focuses on precise neurological localization, differential diagnosis, acute emergencies (stroke, meningitis), chronic conditions (MS, Parkinson's), and neurodegenerative diseases. A strong grasp of neuroanatomy, neurophysiology, and pharmacology is essential for effective diagnosis and management.

Clinical Presentation

  • Headache: Migraine, tension, cluster. Red flags for secondary causes (SAH, tumor, meningitis).
  • Seizures/Epilepsy: Focal/Generalized. Status epilepticus. Rule out structural/metabolic causes.
  • Stroke/TIA: Acute focal neurological deficit. Ischemic vs. Hemorrhagic. Time-sensitive.
  • Movement Disorders: Parkinson's Disease (tremor, rigidity, bradykinesia, postural instability), Essential Tremor.
  • Demyelinating Diseases: Multiple Sclerosis (MS) – relapsing-remitting, progressive. Optic neuritis, myelitis.
  • Neuropathies: Guillain-Barré Syndrome (GBS - acute ascending paralysis), Diabetic Neuropathy, CIDP.
  • Neuromuscular Junction Disorders: Myasthenia Gravis (fluctuating fatigable weakness: ptosis, diplopia, dysphagia).
  • Dementia: Progressive cognitive decline (Alzheimer's, Vascular Dementia, Lewy Body Dementia).
  • Vertigo/Dizziness: Peripheral (BPPV, vestibular neuritis) vs. Central (stroke, MS).
  • Spinal Cord Lesions: Weakness, sensory loss, bladder/bowel dysfunction. Acute myelopathy.

Diagnosis (Gold Standard)

Clinical history and neurological examination are paramount.

  • Neuroimaging:
    • MRI Brain/Spine: Gold standard for stroke, tumors, demyelination (MS), spinal cord pathology.
    • CT Brain: Acute hemorrhage (SAH, ICH), skull fractures, rapid assessment in trauma/acute stroke.
  • Lumbar Puncture (LP) & CSF Analysis: Meningitis, encephalitis, MS (oligoclonal bands), SAH (xanthochromia).
  • Electroencephalography (EEG): Gold standard for diagnosing epilepsy and assessing seizure type/localization.
  • Electromyography (EMG) & Nerve Conduction Studies (NCS): Gold standard for distinguishing neuropathies, myopathies, and neuromuscular junction disorders.
  • Laboratory Tests: Autoantibodies (Myasthenia Gravis), inflammatory markers, genetic testing.

Management (First Line)

  • Acute Ischemic Stroke: IV Thrombolysis (alteplase within 4.5h), Endovascular Thrombectomy. Secondary prevention: antiplatelets (aspirin), statins, BP control.
  • Acute Hemorrhagic Stroke: BP management, reversal of anticoagulation, neurosurgical consultation.
  • Epilepsy/Seizures: First-line AEDs (Levetiracetam, lamotrigine, valproate). Status Epilepticus: IV benzodiazepines.
  • Migraine: Acute (NSAIDs, triptans). Prophylaxis (beta-blockers, topiramate).
  • Multiple Sclerosis: Acute relapses (high-dose IV methylprednisolone). Disease-Modifying Therapies (DMTs) for long-term (e.g., ocrelizumab).
  • Parkinson's Disease: Levodopa (carbidopa/levodopa) for symptomatic relief, dopamine agonists.
  • Myasthenia Gravis: Pyridostigmine, corticosteroids, immunosuppressants. Crisis: IVIg or plasmapheresis.
  • Guillain-Barré Syndrome: IVIg or plasmapheresis (within 2 weeks). Respiratory and hemodynamic support.
  • Bacterial Meningitis: Empirical broad-spectrum IV antibiotics (ceftriaxone + vancomycin) + dexamethasone.
  • Dementia (Alzheimer's): Cholinesterase inhibitors (donepezil) for symptomatic management.
  • Neuropathic Pain: Gabapentin, pregabalin, TCAs (amitriptyline), SNRIs (duloxetine).

Exam Red Flags

  • Thunderclap Headache: Immediate concern for Subarachnoid Hemorrhage (SAH). Requires urgent CT head, followed by LP if CT negative.
  • New Onset Seizure in Adult (>18-20y): Rule out structural lesion (tumor, stroke), infection, metabolic causes.
  • Acute Focal Neurological Deficit (Sudden onset): Stroke until proven otherwise. Requires urgent imaging (CT/MRI).
  • Rapidly Progressive Ascending Weakness (esp. post-infection): Guillain-Barré Syndrome. Monitor respiratory function.
  • Fluctuating Ptosis, Diplopia, Dysphagia, or Generalized Weakness (worsens with exertion): Myasthenia Gravis. Assess for myasthenic crisis.
  • Fever + Headache + Neck Stiffness + Altered Mental Status: Meningitis/Encephalitis. Urgent LP (after imaging if focal signs/papilledema).
  • Papilledema on Fundoscopy: Sign of raised intracranial pressure. Requires urgent investigation (neuroimaging) before LP.
  • Unilateral Painful Vision Loss (especially with eye movement): Optic neuritis (often first presentation of MS).
  • Progressive Unilateral Weakness with Fasciculations and UMN Signs: Amyotrophic Lateral Sclerosis (ALS)/Motor Neuron Disease (MND).
  • Sudden onset of severe dizziness/vertigo with focal neurological signs (ataxia, dysarthria): Central vertigo (posterior circulation stroke).

Sample Practice Questions

Question 1 FULLY WORKED EXAMPLE

A 68-year-old man is brought to the emergency department 90 minutes after sudden onset of left-sided weakness and slurred speech. He has a history of atrial fibrillation and takes warfarin. His blood pressure is 186/104 mmHg, heart rate 88/min and irregular, and blood glucose 7.2 mmol/L. Non-contrast CT of the head shows no hemorrhage. His INR is 2.8. What is the most appropriate next step in management?

A) Intravenous alteplase 0.9 mg/kg
B) Intravenous tenecteplase 0.25 mg/kg
C) Withhold thrombolysis and arrange mechanical thrombectomy assessment ✓ Correct
D) Intravenous unfractionated heparin infusion
Explanation:
The deciding finding is the INR of 2.8, which exceeds the accepted threshold for intravenous thrombolysis in acute ischaemic stroke. Alteplase and tenecteplase are contraindicated when the INR is greater than 1.7, so both thrombolytic options would cause harm from haemorrhage. Mechanical thrombectomy remains the appropriate reperfusion strategy if a large vessel occlusion is confirmed on vascular imaging. Heparin infusion is not indicated as acute reperfusion therapy and increases haemorrhagic risk without proven benefit.
References: AHA/ASA Guidelines for the Early Management of Patients With Acute Ischemic Stroke, 2019
Question 2 TRY IT — TAP AN ANSWER

A 34-year-old woman at 32 weeks' gestation presents with a 3-day history of progressive headache, visual blurring, and one episode of generalised tonic-clonic seizure. Her blood pressure is 168/112 mmHg, and urinalysis shows 3+ proteinuria. Platelet count is 88 x 10^9/L, and serum creatinine is 118 micromol/L. She has no prior history of epilepsy. What is the most appropriate first-line treatment?

A) Intravenous levetiracetam
B) Intravenous magnesium sulfate
C) Intravenous phenytoin
D) Oral sodium valproate
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.
Question 3 TRY IT — TAP AN ANSWER

A 45-year-old man with myasthenia gravis presents with 2 days of worsening bulbar weakness and difficulty breathing. He takes pyridostigmine and prednisolone. His vital capacity is 1.1 L (predicted 4.5 L), and he has nasal flaring and paradoxical abdominal movement. He is afebrile with a normal white cell count. What is the most appropriate immediate management?

A) Increase pyridostigmine dose
B) Intravenous immunoglobulin
C) Urgent intubation and mechanical ventilation
D) High-dose oral prednisolone
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.
Question 4 TRY IT — TAP AN ANSWER

A 72-year-old woman with a mechanical mitral valve on warfarin presents with sudden onset of right hemiplegia and aphasia, onset 2 hours ago. Her blood pressure is 172/94 mmHg, and blood glucose is 6.8 mmol/L. Non-contrast CT shows no hemorrhage. Her INR is 3.4. What is the most appropriate management?

A) Intravenous alteplase
B) Mechanical thrombectomy if large vessel occlusion is confirmed
C) Intravenous tenecteplase
D) Immediate reversal of anticoagulation with vitamin K and prothrombin complex concentrate
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.
Question 5 TRY IT — TAP AN ANSWER

A 28-year-old man presents with a 5-day history of progressive confusion, fever, and a generalised seizure. He has no rash. His temperature is 38.9 degrees C, and he is disoriented to time and place. Cerebrospinal fluid shows lymphocytic pleocytosis with 120 cells/microlitre, normal glucose, and elevated protein. Non-contrast CT of the head is normal. What is the most appropriate next step?

A) Start intravenous aciclovir immediately
B) Wait for CSF PCR results before starting treatment
C) Start intravenous ceftriaxone alone
D) Start oral prednisolone
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.

Want 268+ more Specialist Neurology (NRO5011) questions?

Start Free — No Card Needed

DHA Speciality

  • ✓ 268+ Specialist Neurology (NRO5011) Questions
  • ✓ AI Tutor Assistance
  • ✓ Detailed Explanations
  • ✓ Performance Analytics
Get Full Access

Specialist Neurology (NRO5011) Questions for DHA Speciality — FAQ

How many Specialist Neurology (NRO5011) questions does MedLumen have for DHA Speciality?

MedLumen currently has 268+ Specialist Neurology (NRO5011) practice questions for DHA Speciality, each with a detailed explanation so you understand the reasoning behind every answer.

Are the Specialist Neurology (NRO5011) questions updated for the 2026 DHA Speciality syllabus?

Yes. Our Specialist Neurology (NRO5011) questions are mapped to the latest DHA Speciality blueprint and reviewed regularly so they stay aligned with the current 2026 syllabus.

Can I practise Specialist Neurology (NRO5011) questions for free?

You can preview sample Specialist Neurology (NRO5011) questions for free. A MedLumen subscription unlocks all 268+ Specialist Neurology (NRO5011) questions, full answer explanations, and performance analytics for DHA Speciality.

How should I revise Specialist Neurology (NRO5011) for DHA Speciality?

Practise Specialist Neurology (NRO5011) questions in timed blocks, read the explanation for every answer (right or wrong), and use MedLumen's analytics to revisit your weak areas until your accuracy is consistently high.

Prepare for DHA Speciality with MedLumen →

Explore Other DHA Speciality Topics

Specialist Ophthalmology (OPH5841)
Specialist Urology (URO5931)
Specialist Plastic Surgery (PLA5671)
Specialist Anesthesia (ANA5781)
Specialist Pulmonary Disease (PUL5081)
Specialist Pediatric Surgery (PED5492)
Specialist Obstetrics & Gynecology (OBG5891)
Specialist Clinical Pathology (CPA5541)
Specialist Neurosurgery (NEU5311)
Specialist General Surgery (GEN5341)
Specialist Anatomic Pathology (HIS5571)
Specialist Physical Medicine & Rehabilitation (PHY5261)
View All Topics →